243 related articles for article (PubMed ID: 20810784)
21. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
[TBL] [Abstract][Full Text] [Related]
22. The two-stage pathway of ataxin-3 fibrillogenesis involves a polyglutamine-independent step.
Ellisdon AM; Thomas B; Bottomley SP
J Biol Chem; 2006 Jun; 281(25):16888-16896. PubMed ID: 16624810
[TBL] [Abstract][Full Text] [Related]
23. Examination of Ataxin-3 (atx-3) Aggregation by Structural Mass Spectrometry Techniques: A Rationale for Expedited Aggregation upon Polyglutamine (polyQ) Expansion.
Scarff CA; Almeida B; Fraga J; Macedo-Ribeiro S; Radford SE; Ashcroft AE
Mol Cell Proteomics; 2015 May; 14(5):1241-53. PubMed ID: 25700012
[TBL] [Abstract][Full Text] [Related]
24. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
Mueller T; Breuer P; Schmitt I; Walter J; Evert BO; Wüllner U
Hum Mol Genet; 2009 Sep; 18(17):3334-43. PubMed ID: 19542537
[TBL] [Abstract][Full Text] [Related]
25. Conformational targeting of fibrillar polyglutamine proteins in live cells escalates aggregation and cytotoxicity.
Kvam E; Nannenga BL; Wang MS; Jia Z; Sierks MR; Messer A
PLoS One; 2009 May; 4(5):e5727. PubMed ID: 19492089
[TBL] [Abstract][Full Text] [Related]
26. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
[TBL] [Abstract][Full Text] [Related]
27. A major role for side-chain polyglutamine hydrogen bonding in irreversible ataxin-3 aggregation.
Natalello A; Frana AM; Relini A; Apicella A; Invernizzi G; Casari C; Gliozzi A; Doglia SM; Tortora P; Regonesi ME
PLoS One; 2011 Apr; 6(4):e18789. PubMed ID: 21533208
[TBL] [Abstract][Full Text] [Related]
28. Amino acid sequences flanking polyglutamine stretches influence their potential for aggregate formation.
Nozaki K; Onodera O; Takano H; Tsuji S
Neuroreport; 2001 Oct; 12(15):3357-64. PubMed ID: 11711886
[TBL] [Abstract][Full Text] [Related]
29. [Recent advances in molecular genetics of spinocerebellar ataxia type 3/Machado-Joseph disease].
Jia D; Jiang H; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):660-2. PubMed ID: 19065526
[TBL] [Abstract][Full Text] [Related]
30. Nucleocytoplasmic shuttling activity of ataxin-3.
Macedo-Ribeiro S; Cortes L; Maciel P; Carvalho AL
PLoS One; 2009 Jun; 4(6):e5834. PubMed ID: 19503814
[TBL] [Abstract][Full Text] [Related]
31. Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3.
Haacke A; Hartl FU; Breuer P
J Biol Chem; 2007 Jun; 282(26):18851-6. PubMed ID: 17488727
[TBL] [Abstract][Full Text] [Related]
32. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.
Nicastro G; Menon RP; Masino L; Knowles PP; McDonald NQ; Pastore A
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10493-8. PubMed ID: 16020535
[TBL] [Abstract][Full Text] [Related]
33. Misfolding promotes the ubiquitination of polyglutamine-expanded ataxin-3, the defective gene product in SCA3/MJD.
Jana NR; Nukina N
Neurotox Res; 2004; 6(7-8):523-33. PubMed ID: 15639784
[TBL] [Abstract][Full Text] [Related]
34. Novel polyglutamine model uncouples proteotoxicity from aging.
Christie NT; Lee AL; Fay HG; Gray AA; Kikis EA
PLoS One; 2014; 9(5):e96835. PubMed ID: 24817148
[TBL] [Abstract][Full Text] [Related]
35. Polyglutamine-Independent Features in Ataxin-3 Aggregation and Pathogenesis of Machado-Joseph Disease.
Carvalho AL; Silva A; Macedo-Ribeiro S
Adv Exp Med Biol; 2018; 1049():275-288. PubMed ID: 29427109
[TBL] [Abstract][Full Text] [Related]
36. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation.
Perez MK; Paulson HL; Pendse SJ; Saionz SJ; Bonini NM; Pittman RN
J Cell Biol; 1998 Dec; 143(6):1457-70. PubMed ID: 9852144
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional analysis of ataxin-2 and ataxin-3.
Albrecht M; Golatta M; Wüllner U; Lengauer T
Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
[TBL] [Abstract][Full Text] [Related]
38. The role of the central flexible region on the aggregation and conformational properties of human ataxin-3.
Santambrogio C; Frana AM; Natalello A; Papaleo E; Regonesi ME; Doglia SM; Tortora P; Invernizzi G; Grandori R
FEBS J; 2012 Feb; 279(3):451-63. PubMed ID: 22129356
[TBL] [Abstract][Full Text] [Related]
39. Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties.
Harris GM; Dodelzon K; Gong L; Gonzalez-Alegre P; Paulson HL
PLoS One; 2010 Oct; 5(10):e13695. PubMed ID: 21060878
[TBL] [Abstract][Full Text] [Related]
40. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]